Market open
Anika Therapeutics/$ANIK
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Anika Therapeutics
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
Ticker
$ANIK
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
357
Website
ANIK Metrics
BasicAdvanced
$255M
-
-$6.62
0.83
-
Price and volume
Market cap
$255M
Beta
0.83
52-week high
$29.12
52-week low
$15.40
Average daily volume
61K
Financial strength
Current ratio
5.339
Quick ratio
3.559
Long term debt to equity
14.034
Total debt to equity
15.308
Management effectiveness
Return on assets (TTM)
-4.01%
Return on equity (TTM)
-43.31%
Valuation
Price to revenue (TTM)
1.565
Price to book
1.42
Price to tangible book (TTM)
1.51
Price to free cash flow (TTM)
-182.452
Growth
Revenue change (TTM)
0.52%
Earnings per share change (TTM)
294.13%
3-year revenue growth (CAGR)
4.31%
3-year earnings per share growth (CAGR)
154.97%
What the Analysts think about ANIK
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Anika Therapeutics stock.
ANIK Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ANIK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ANIK News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Anika Therapeutics stock?
Anika Therapeutics (ANIK) has a market cap of $255M as of February 25, 2025.
What is the P/E ratio for Anika Therapeutics stock?
The price to earnings (P/E) ratio for Anika Therapeutics (ANIK) stock is 0 as of February 25, 2025.
Does Anika Therapeutics stock pay dividends?
No, Anika Therapeutics (ANIK) stock does not pay dividends to its shareholders as of February 25, 2025.
When is the next Anika Therapeutics dividend payment date?
Anika Therapeutics (ANIK) stock does not pay dividends to its shareholders.
What is the beta indicator for Anika Therapeutics?
Anika Therapeutics (ANIK) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.